What's New

6 March 2024

At the meeting of 6 February 2024 the RMA:

Determined Statements of Principles (SOPs) for:

Condition SOPs
seborrhoeic keratosis 19/2024 20/2024
acute myeloid leukaemia 21/2024 22/2024
osteomyelitis 23/2024 24/2024
hallux valgus 25/2024 26/2024

These SOPs revoke the SOPs previously determined for these conditions.

Determined New Statements of Principles (SOPs) for:

Condition SOPs
myocarditis 17/2024 18/2024

Determined Amendment Statements of Principles (SOPs) for:

Condition SOPs
malignant neoplasm of the lung 27/2024
soft tissue sarcoma 27/2024
Hodgkin lymphoma 27/2024
malignant neoplasm of the prostate 27/2024
malignant neoplasm of the larynx 27/2024
myeloma 27/2024
non-Hodgkin lymphoma 27/2024
depressive disorder 28/2024
cervical intervertebral disc prolapse 29/2024 30/2024

Determined to revoke and not reissue Statements of Principles (SOPs) for:

Condition SOPs
horseshoe kidney 31/2015 32/2015

The above SOPs and Revocations take effect from 26 March 2024.

Finalised Declarations for:

Condition Declaration Reasons for Decision
new daily persistent headache
horseshoe kidney

Completed Investigations

The above determinations, declarations and revocations conclude the previously advertised investigations into:

The above declaration notices appear in the Government Notices Gazette of 28 February 2024.